SinoMab BioScience Limited (3681.HK)
HKD 1.03
(-1.9%)
HKD 1.03
(-1.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -133.84 Million | -300.53 Million | -147.06 Million | -141.33 Million | -222.48 Million | -46.82 Million |
| Net Income | -243.11 Million | -284.15 Million | -288.19 Million | -122.6 Million | -276.28 Million | -83.61 Million |
| Depreciation & Amortization | 36.06 Million | 27.03 Million | 20.32 Million | 10.67 Million | 8.48 Million | 5.34 Million |
| Deferred income taxes | - | 18.25 Million | -109.53 Million | 4.32 Million | - | - |
| Stock-based compensation | 18.99 Million | 5.01 Million | 62.89 Million | 34.9 Million | - | - |
| Change in working capital | 48.34 Million | -23.27 Million | 46.64 Million | -39.22 Million | 42.95 Million | 5.78 Million |
| Other non-cash items | 408 Thousand | -43.41 Million | 120.81 Million | -29.41 Million | 2.34 Million | 25.65 Million |
| Investing Cash Flow | -96.92 Million | -81.35 Million | -137.7 Million | -179.21 Million | -42.28 Million | 21.46 Million |
| Investments in PPE | -103.89 Million | -112.75 Million | -198.23 Million | -75.95 Million | -42.28 Million | -2.74 Million |
| Acquisitions | - | 33.36 Million | -16.17 Million | -17.33 Million | - | 22.35 Million |
| Investment purchases | -41 Million | -75 Million | -85 Million | -69.56 Million | - | - |
| Sales/Maturities of investments | 41.11 Million | 75.56 Million | 177.04 Million | 86.89 Million | - | - |
| Other Investing Activities | 6.85 Million | -2.53 Million | -15.34 Million | -103.26 Million | - | 1.85 Million |
| Financing Cash Flow | 82.26 Million | 102.28 Million | 57.51 Million | -18.8 Million | 1.42 Billion | -3.55 Million |
| Debt repayment | -100.93 Million | -10.56 Million | -21.43 Million | -6.28 Million | -10 Million | -160 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -59.67 Million | - | - | - |
| Common Stock Issuance | 10.03 Million | 46.08 Million | -59.67 Million | - | 1.43 Billion | 150 Million |
| Other Financing Activities | 82.26 Million | 66.76 Million | 339.07 Million | -12.52 Million | -6.65 Million | 6.44 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 60.65 Million | -23.27 Million | 46.64 Million | -39.22 Million | 42.95 Million | 5.22 Million |
| Cash at beginning of period | 342.88 Million | 562.98 Million | 810.37 Million | 1.2 Billion | 41.51 Million | 66.09 Million |
| Cash at end of period | 203.66 Million | 342.88 Million | 562.98 Million | 810.37 Million | 1.2 Billion | 41.51 Million |
| Capital Expenditure | -103.89 Million | -112.75 Million | -198.23 Million | -75.95 Million | -42.28 Million | -2.74 Million |
| Effect of forex changes on cash | 9.27 Million | 59.51 Million | -20.13 Million | -51.13 Million | 3.32 Million | 4.33 Million |
| Net cash flow / Change in cash | -139.22 Million | -220.09 Million | -247.38 Million | -390.49 Million | 1.15 Billion | -24.58 Million |
| Free Cash Flow | -237.73 Million | -413.28 Million | -345.29 Million | -217.29 Million | -264.77 Million | -49.57 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -90.62 Million | -243.11 Million | -109.01 Million | -134.09 Million | -284.15 Million | -140.36 Million |
| Depreciation & Amortization | - | 36.06 Million | 36.06 Million | - | 27.03 Million | 27.03 Million |
| Deferred income taxes | - | - | - | - | 18.25 Million | - |
| Stock-based compensation | - | 18.99 Million | 18.99 Million | - | 5.01 Million | 5.01 Million |
| Change in working capital | - | 48.34 Million | 60.65 Million | - | -23.27 Million | -12.43 Million |
| Other non-cash items | 20.03 Million | 408 Thousand | -77.79 Million | 71.34 Million | -43.41 Million | -34.19 Million |
| Investing Cash Flow | -76.39 Million | -96.92 Million | -34.97 Million | -61.94 Million | -81.35 Million | 20.32 Million |
| Investments in PPE | -28.09 Million | -103.89 Million | -42.08 Million | -61.25 Million | -112.75 Million | -52.08 Million |
| Acquisitions | - | - | - | - | 33.36 Million | - |
| Investment purchases | - | -41 Million | - | - | -75 Million | - |
| Sales/Maturities of investments | - | 41.11 Million | - | - | 75.56 Million | - |
| Other Investing Activities | -48.29 Million | 6.85 Million | 7.1 Million | -689 Thousand | -2.53 Million | 72.4 Million |
| Financing Cash Flow | 93.44 Million | 82.26 Million | 40.22 Million | 42.04 Million | 102.28 Million | 81.38 Million |
| Debt repayment | -39.69 Million | -100.93 Million | - | -45.28 Million | -10.56 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 10.03 Million | - | - | 46.08 Million | - |
| Other Financing Activities | 53.75 Million | 82.26 Million | 40.22 Million | -3.23 Million | 66.76 Million | 81.38 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 60.65 Million | 60.65 Million | - | -23.27 Million | -12.43 Million |
| Cash at beginning of period | 203.66 Million | 342.88 Million | 282.21 Million | 345.71 Million | 562.98 Million | 367.38 Million |
| Cash at end of period | 153.61 Million | 203.66 Million | 206.48 Million | 282.21 Million | 342.88 Million | 342.88 Million |
| Capital Expenditure | -28.09 Million | -103.89 Million | -42.08 Million | -61.25 Million | -112.75 Million | -52.08 Million |
| Effect of forex changes on cash | 3.48 Million | 9.27 Million | -9.86 Million | 19.14 Million | 59.51 Million | 28.74 Million |
| Net cash flow / Change in cash | -50.04 Million | -139.22 Million | -75.72 Million | -63.5 Million | -220.09 Million | -24.5 Million |
| Free Cash Flow | -98.68 Million | -237.73 Million | -113.18 Million | -124 Million | -413.28 Million | -207.03 Million |
SEM
600629
6629
SBKFF
TPB
CVLG